Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 102

1.

Projecting the clinical benefits of adjuvant radiotherapy versus observation and selective salvage radiotherapy after radical prostatectomy: a decision analysis.

Elliott SP, Wilt TJ, Kuntz KM.

Prostate Cancer Prostatic Dis. 2011 Sep;14(3):270-7. doi: 10.1038/pcan.2011.27. Epub 2011 Jun 21.

2.

A Phase III trial to investigate the timing of radiotherapy for prostate cancer with high-risk features: background and rationale of the Radiotherapy -- Adjuvant Versus Early Salvage (RAVES) trial.

Pearse M, Fraser-Browne C, Davis ID, Duchesne GM, Fisher R, Frydenberg M, Haworth A, Jose C, Joseph DJ, Lim TS, Matthews J, Millar J, Sidhom M, Spry NA, Tang CI, Turner S, Williams SG, Wiltshire K, Woo HH, Kneebone A.

BJU Int. 2014 Mar;113 Suppl 2:7-12. doi: 10.1111/bju.12623.

3.

Long-term rates of undetectable PSA with initial observation and delayed salvage radiotherapy after radical prostatectomy.

Loeb S, Roehl KA, Viprakasit DP, Catalona WJ.

Eur Urol. 2008 Jul;54(1):88-94. doi: 10.1016/j.eururo.2008.03.066. Epub 2008 Apr 1.

PMID:
18400368
4.

Adjuvant and salvage radiotherapy after prostatectomy: AUA/ASTRO Guideline.

Thompson IM, Valicenti RK, Albertsen P, Davis BJ, Goldenberg SL, Hahn C, Klein E, Michalski J, Roach M, Sartor O, Wolf JS Jr, Faraday MM.

J Urol. 2013 Aug;190(2):441-9. doi: 10.1016/j.juro.2013.05.032. Epub 2013 May 21.

PMID:
23707439
5.

Adjuvant and salvage radiotherapy after radical prostatectomy for prostate cancer.

Taylor N, Kelly JF, Kuban DA, Babaian RJ, Pisters LL, Pollack A.

Int J Radiat Oncol Biol Phys. 2003 Jul 1;56(3):755-63.

PMID:
12788182
6.

Decipher test impacts decision making among patients considering adjuvant and salvage treatment after radical prostatectomy: Interim results from the Multicenter Prospective PRO-IMPACT study.

Gore JL, du Plessis M, Santiago-Jiménez M, Yousefi K, Thompson DJS, Karsh L, Lane BR, Franks M, Chen DYT, Bandyk M, Bianco FJ Jr, Brown G, Clark W, Kibel AS, Kim HL, Lowrance W, Manoharan M, Maroni P, Perrapato S, Sieber P, Trabulsi EJ, Waterhouse R, Davicioni E, Lotan Y, Lin DW.

Cancer. 2017 Aug 1;123(15):2850-2859. doi: 10.1002/cncr.30665. Epub 2017 Apr 19.

PMID:
28422278
7.

Radiotherapy after radical prostatectomy: immediate or early delayed?

Bottke D, Bartkowiak D, Schrader M, Wiegel T.

Strahlenther Onkol. 2012 Dec;188(12):1096-101. doi: 10.1007/s00066-012-0234-9. Epub 2012 Nov 7.

PMID:
23128897
8.

Does neoadjuvant hormone therapy improve outcome in prostate cancer patients receiving radiotherapy after radical prostatectomy?

Pai HH, Eldridge B, Bishop D, Alexander A, Lesperance M, Blood P, Lim J, Ludgate C.

Can J Urol. 2009 Apr;16(2):4541-52.

PMID:
19364426
9.

Adjuvant radiotherapy for pathologically advanced prostate cancer: a randomized clinical trial.

Thompson IM Jr, Tangen CM, Paradelo J, Lucia MS, Miller G, Troyer D, Messing E, Forman J, Chin J, Swanson G, Canby-Hagino E, Crawford ED.

JAMA. 2006 Nov 15;296(19):2329-35.

PMID:
17105795
10.

The timing of salvage radiotherapy after radical prostatectomy: a systematic review.

King CR.

Int J Radiat Oncol Biol Phys. 2012 Sep 1;84(1):104-11. doi: 10.1016/j.ijrobp.2011.10.069. Epub 2012 Jul 14. Review.

PMID:
22795730
11.

Early salvage radiation therapy post-prostatectomy: key considerations.

Morlacco A, Karnes RJ.

Future Oncol. 2016 Nov;12(22):2579-2587. doi: 10.2217/fon-2016-0208. Epub 2016 Jul 8.

PMID:
27387852
12.

Early salvage radiation therapy does not compromise cancer control in patients with pT3N0 prostate cancer after radical prostatectomy: results of a match-controlled multi-institutional analysis.

Briganti A, Wiegel T, Joniau S, Cozzarini C, Bianchi M, Sun M, Tombal B, Haustermans K, Budiharto T, Hinkelbein W, Di Muzio N, Karakiewicz PI, Montorsi F, Van Poppel H.

Eur Urol. 2012 Sep;62(3):472-87. doi: 10.1016/j.eururo.2012.04.056. Epub 2012 May 16.

PMID:
22633803
13.

[Adjuvant vs. salvage radiotherapy after radical prostatectomy].

Bartkowiak D, Schrader AJ, Wiegel T.

Aktuelle Urol. 2015 Jan;46(1):52-8. doi: 10.1055/s-0034-1395656. Epub 2015 Feb 6. Review. German.

PMID:
25658231
14.

Postoperative radiation therapy for patients at high-risk of recurrence after radical prostatectomy: does timing matter?

Hsu CC, Paciorek AT, Cooperberg MR, Roach M 3rd, Hsu IC, Carroll PR.

BJU Int. 2015 Nov;116(5):713-20. doi: 10.1111/bju.13043. Epub 2015 May 26.

15.

Adjuvant versus salvage radiation therapy for prostate cancer patients with adverse pathologic features: comparative analysis of long-term outcomes.

Mishra MV, Scher ED, Andrel J, Margules AC, Hegarty SE, Trabulsi EJ, Hyslop T, Den RB, Lallas CD, Gomella LG, Dicker AP, Showalter TN.

Am J Clin Oncol. 2015 Feb;38(1):55-60. doi: 10.1097/COC.0b013e318287bb6b.

PMID:
24051934
16.

Adjuvant radiotherapy versus wait-and-see after radical prostatectomy: 10-year follow-up of the ARO 96-02/AUO AP 09/95 trial.

Wiegel T, Bartkowiak D, Bottke D, Bronner C, Steiner U, Siegmann A, Golz R, Störkel S, Willich N, Semjonow A, Stöckle M, Rübe C, Rebmann U, Kälble T, Feldmann HJ, Wirth M, Hofmann R, Engenhart-Cabillic R, Hinke A, Hinkelbein W, Miller K.

Eur Urol. 2014 Aug;66(2):243-50. doi: 10.1016/j.eururo.2014.03.011. Epub 2014 Mar 21.

PMID:
24680359
17.

Primary radiotherapy versus radical prostatectomy for high-risk prostate cancer: a decision analysis.

Parikh R, Sher DJ.

Cancer. 2012 Jan 1;118(1):258-67. doi: 10.1002/cncr.26272. Epub 2011 Jun 30.

18.
19.

Predicting the outcome of salvage radiation therapy for recurrent prostate cancer after radical prostatectomy.

Stephenson AJ, Scardino PT, Kattan MW, Pisansky TM, Slawin KM, Klein EA, Anscher MS, Michalski JM, Sandler HM, Lin DW, Forman JD, Zelefsky MJ, Kestin LL, Roehrborn CG, Catton CN, DeWeese TL, Liauw SL, Valicenti RK, Kuban DA, Pollack A.

J Clin Oncol. 2007 May 20;25(15):2035-41. Erratum in: J Clin Oncol. 2007 Sep 10;25(26):4153.

20.

Adjuvant and salvage radiation therapy after radical prostatectomy for adenocarcinoma of the prostate.

Catton C, Gospodarowicz M, Warde P, Panzarella T, Catton P, McLean M, Milosevic M.

Radiother Oncol. 2001 Apr;59(1):51-60.

PMID:
11295206

Supplemental Content

Support Center